These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1091 related articles for article (PubMed ID: 19717287)
1. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
2. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization. Xu H; Zhong H; Liu M; Xu C; Gao Y Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119 [TBL] [Abstract][Full Text] [Related]
3. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
4. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release. Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022 [TBL] [Abstract][Full Text] [Related]
5. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method. Jelvehgari M; Atapour F; Nokhodchi A Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883 [TBL] [Abstract][Full Text] [Related]
6. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Kumar PS; Ramakrishna S; Saini TR; Diwan PV Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069 [TBL] [Abstract][Full Text] [Related]
7. Study of gamma-irradiation effects on aciclovir poly(D,L-lactic-co-glycolic) acid microspheres for intravitreal administration. Martínez-Sancho C; Herrero-Vanrell R; Negro S J Control Release; 2004 Sep; 99(1):41-52. PubMed ID: 15342179 [TBL] [Abstract][Full Text] [Related]
8. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system. Han Y; Tian H; He P; Chen X; Jing X Int J Pharm; 2009 Aug; 378(1-2):159-66. PubMed ID: 19465100 [TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique. Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816 [TBL] [Abstract][Full Text] [Related]
10. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Díez S; Tros de Ilarduya C Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172 [TBL] [Abstract][Full Text] [Related]
11. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. Bae SE; Son JS; Park K; Han DK J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089 [TBL] [Abstract][Full Text] [Related]
12. Nanostructured microspheres produced by supercritical fluid extraction of emulsions. Della Porta G; Reverchon E Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122 [TBL] [Abstract][Full Text] [Related]
13. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres. Yang Y; Gao Y; Mei X Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467 [TBL] [Abstract][Full Text] [Related]
14. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone. da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313 [TBL] [Abstract][Full Text] [Related]
15. A novel preparation method for PLGA microspheres using non-halogenated solvents. Matsumoto A; Kitazawa T; Murata J; Horikiri Y; Yamahara H J Control Release; 2008 Aug; 129(3):223-7. PubMed ID: 18562036 [TBL] [Abstract][Full Text] [Related]
16. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres. Hsu YY; Hao T; Hedley ML J Drug Target; 1999 Dec; 7(4):313-23. PubMed ID: 10682910 [TBL] [Abstract][Full Text] [Related]
17. Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate. Yin J; Noda Y; Yotsuyanagi T Int J Pharm; 2006 May; 314(1):46-55. PubMed ID: 16551494 [TBL] [Abstract][Full Text] [Related]
18. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method. Uchida T; Yagi A; Oda Y; Goto S J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988 [TBL] [Abstract][Full Text] [Related]
19. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology. Emami J; Hamishehkar H; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Mirzadeh H; Fakhari A; Nokhodchi A J Microencapsul; 2009 Feb; 26(1):1-8. PubMed ID: 18465287 [TBL] [Abstract][Full Text] [Related]
20. Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres. Xu Q; Czernuszka JT J Control Release; 2008 Apr; 127(2):146-53. PubMed ID: 18325617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]